In a cohort of 38 patients with SPAs, consisting of hormone-negative and gonadotroph adenomas, preoperative serum showed a median LH/FSH ratio of 0.33:1, with 35 of 38 patients presenting with LH/FSH ratios <1.0. Here, BRD2 is linked to functioning gonadotropic adenoma.